tiprankstipranks
Aurinia Pharmaceuticals (DE:IKAP)
NASDAQ:IKAP
Germany Market

Aurinia Pharmaceuticals (IKAP) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Aurinia Pharmaceuticals’s (IKAP) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Aurinia Pharmaceuticals is a Buy.
Aurinia Pharmaceuticals’s (IKAP) 20-Day exponential moving average is 13.18, while Aurinia Pharmaceuticals’s (IKAP) share price is €13.53, making it a Buy.
Aurinia Pharmaceuticals’s (IKAP) 50-Day exponential moving average is 13.11, while Aurinia Pharmaceuticals’s (IKAP) share price is €13.53, making it a Buy.

Aurinia Pharmaceuticals (IKAP) Pivot Points

Jun 05, 2026, 10:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.73
12.80
12.95
13.02
13.16
13.23
13.38
Fibonacci
12.80
12.89
12.94
13.02
13.10
13.15
13.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aurinia Pharmaceuticals (IKAP) Moving Averages

Jun 05, 2026, 10:17 AM
Period
Simple
Exponential
MA5
13.08Buy
13.15Buy
MA10
13.09Buy
13.14Buy
MA20
13.18Buy
13.18Buy
MA50
13.22Buy
13.11Buy
MA100
12.75Buy
12.79Buy
MA200
12.20Buy
11.75Buy
Aurinia Pharmaceuticals’s (IKAP) 10-Day exponential moving average is 13.14, while Aurinia Pharmaceuticals’s (IKAP) share price is €13.53, making it a Buy.
Aurinia Pharmaceuticals’s (IKAP) 100-Day exponential moving average is 12.79, while Aurinia Pharmaceuticals’s (IKAP) share price is €13.53, making it a Buy.
Aurinia Pharmaceuticals’s (IKAP) stock price is €13.53 and Aurinia Pharmaceuticals’s (IKAP) 50-day simple moving average is 13.22, creating a Buy signal.
Aurinia Pharmaceuticals’s (IKAP) stock price is €13.53 and Aurinia Pharmaceuticals’s (IKAP) 100-day simple moving average is 12.75, creating a Buy signal.
Aurinia Pharmaceuticals’s (IKAP) stock price is €13.53 and Aurinia Pharmaceuticals’s (IKAP) 200-day simple moving average is 12.20, creating a Buy signal.

Aurinia Pharmaceuticals (IKAP) Technical Indicators

Jun 05, 2026, 10:17 AM
Name
Value
Implied Action
RSI (14)
53.27
Neutral
STOCH (9,6)
40.31
Neutral
STOCHRSI (14)
37.79
Neutral
MACD (12,26)
-0.04
Buy
ADX (14)
11.04
Buy
Williams %R
-39.57
Buy
CCI (14)
108.12
Sell
ATR (14)
0.31
-
Ultimate Oscillator
54.86
Neutral
ROC
-1.36
Sell
Aurinia Pharmaceuticals’s (IKAP) Relative Strength Index (RSI) is 53.27, creating a Neutral signal.
Aurinia Pharmaceuticals’s (IKAP) Trend Strength Indicator (ADX) is 11.04, creating a Buy signal.
Aurinia Pharmaceuticals’s (IKAP) Commodity Channel Index (CCI) is 108.12, creating a Sell signal.
Aurinia Pharmaceuticals’s (IKAP) Price Rate of Change (ROC) is -1.36, creating a Sell signal.

FAQ

Is IKAP a Buy, Hold, or Sell?
Based on IKAP’s technical indicators, IKAP is a Strong Buy.
    What is IKAP’s RSI (14)?
    IKAP’s RSI (14) is 53.27, which suggests IKAP is a Neutral.
      What is IKAP’s MACD?
      IKAP’s MACD is -0.04, which suggests IKAP is a Buy.
        What is IKAP’s 5-day moving average?
        IKAP’s 5-day moving average is 13.08, which suggests IKAP is a Buy.
          What is IKAP’s 20-day moving average?
          IKAP 20-day moving average is 13.18, which suggests IKAP is a Buy.
            What is IKAP’s 50-day moving average?
            IKAP’s 50-day moving average is 13.22, which suggests IKAP is a Buy.
              What is IKAP’s 200-day moving average?
              IKAP’s 200-day moving average is 12.20, which suggests IKAP is a Buy.
                What is IKAP’s Williams % R (14)?
                IKAP’s Williams % R (14) is -39.57, which suggests IKAP is a Buy.
                  What is IKAP’s CCI (14)?
                  IKAP’s CCI (14) is 108.12, which suggests IKAP is a Sell.
                    What is the share price of Aurinia Pharmaceuticals?